Evidence map›Paper›PMID 25915851›Full record

ArticleThe Biochemical journal2015

Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.

Ying Liu, Sanjana Sen, Sivaporn Wannaiampikul, Rengasamy Palanivel, Ruby L C Hoo, Ruth Isserlin, Gary D Bader, Rungsunn Tungtrongchitr, Yves Deshaies, Aimin Xu and 1 more

Abstract read
In one paragraph

Article in The Biochemical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Ying LiuDepartment of Biology, York University, Toronto, Ontario, Canada, M3J 1P3.
Sanjana SenDepartment of Biology, York University, Toronto, Ontario, Canada, M3J 1P3.
Sivaporn WannaiampikulDepartment of Biology, York University, Toronto, Ontario, Canada, M3J 1P3 Department of Tropical Nutrition and Food Science, Mahidol University, Bangkok 10400, Thailand.
Rengasamy PalanivelDepartment of Biology, York University, Toronto, Ontario, Canada, M3J 1P3.
Ruby L C HooState Key Laboratory of Pharmaceutical Biotechnology, and Department of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
Ruth IsserlinThe Donnelly Centre, University of Toronto, 160 College Street, Toronto, Ontario, Canada, M5S 3E1.
Gary D BaderThe Donnelly Centre, University of Toronto, 160 College Street, Toronto, Ontario, Canada, M5S 3E1.
Rungsunn TungtrongchitrDepartment of Tropical Nutrition and Food Science, Mahidol University, Bangkok 10400, Thailand.
Yves DeshaiesDepartment of Medicine and Québec Heart & Lung Institute Research Centre, Université Laval, Québec City, Québec, Canada, G1V 4G5.
Aimin XuState Key Laboratory of Pharmaceutical Biotechnology, and Department of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
Gary SweeneyDepartment of Biology, York University, Toronto, Ontario, Canada, M3J 1P3 gsweeney@yorku.ca.
York University · CAMahidol University · THUniversity of Hong Kong · HKUniversity of Toronto · CAUniversité Laval · CA

Funding

TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
Cytoscape: A Modeling Platform for Biomolecular NetworksR01GM070743 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2004 to 2016
$5.7M
Knowledge-based Gene Expression Analysis for Biomedical and Cancer ResearchR01CA121941 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MESIROV, JILL P. · 2006 to 2016
$5.1M
Pathway Commons: Research Resource for Biological PathwaysP41HG004118 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI SANDER, CHRIS · 2008 to 2011
$3.8M
Canadian Institutes of Health ResearchNCI NIH HHS R01 CA121941NHGRI NIH HHS P41 HG004118NIGMS NIH HHS P41 GM103504NIGMS NIH HHS R01 GM070743
6 · The paper itself

Abstract

Adiponectin mediates anti-diabetic effects via increasing hepatic insulin sensitivity and direct metabolic effects. In the present study, we conducted a comprehensive and unbiased metabolomic profiling of liver tissue from AdKO (adiponectin-knockout) mice, with and without adiponectin supplementation, fed on an HFD (high-fat diet) to derive insight into the mechanisms and consequences of insulin resistance. Hepatic lipid accumulation and insulin resistance induced by the HFD were reduced by adiponectin. The HFD significantly altered levels of 147 metabolites, and bioinformatic analysis indicated that one of the most striking changes was the profile of increased lysophospholipids. These changes were largely corrected by adiponectin, at least in part via direct regulation of PLA2 (phospholipase A2) as palmitate-induced PLA2 activation was attenuated by adiponectin in primary hepatocytes. Notable decreases in several glycerolipids after the HFD were reversed by adiponectin, which also corrected elevations in several diacyglycerol and ceramide species. Our data also indicate that stimulation of ω-oxidation of fatty acids by the HFD is enhanced by adiponectin. In conclusion, this metabolomic profiling approach in AdKO mice identified important targets of adiponectin action, including PLA2, to regulate lysophospholipid metabolism and ω-oxidation of fatty acids.

Indexed as

AdiponectinAnimalsHepatocytesLipid MetabolismLiverLysophospholipidsMetabolomeMetabolomicsMiceMice, KnockoutPhospholipases A2AdiponectinAdipoq protein, mouseLysophospholipidsPhospholipases A2adiponectinhigh-fat dietinsulinlipidliverphospholipase

Identifiers

PMID25915851
PMCPMC4828338
OpenAlexW2031268723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.